CNN-FL for Biotechnology Industry Empowered by Internet-of-BioNano Things and Digital Twins
This work addresses the problem of improving digital twin modeling for complex biological entities like bacteria, which is crucial for applications in biotechnology, pharmaceuticals, and healthcare, though it appears incremental as it combines existing technologies in a novel way.
The paper tackles the challenge of creating accurate and scalable digital twins for microorganisms in biotechnology by proposing a framework that integrates Internet of Bio-Nano Things (IoBNT) with convolutional neural networks (CNN) and federated learning (FL), resulting in enhanced reliability, safety, energy efficiency, and security while preserving accuracy.
Digital twins (DTs) are revolutionizing the biotechnology industry by enabling sophisticated digital representations of biological assets, microorganisms, drug development processes, and digital health applications. However, digital twinning at micro and nano scales, particularly in modeling complex entities like bacteria, presents significant challenges in terms of requiring advanced Internet of Things (IoT) infrastructure and computing approaches to achieve enhanced accuracy and scalability. In this work, we propose a novel framework that integrates the Internet of Bio-Nano Things (IoBNT) with advanced machine learning techniques, specifically convolutional neural networks (CNN) and federated learning (FL), to effectively tackle the identified challenges. Within our framework, IoBNT devices are deployed to gather image-based biological data across various physical environments, leveraging the strong capabilities of CNNs for robust machine vision and pattern recognition. Subsequently, FL is utilized to aggregate insights from these disparate data sources, creating a refined global model that continually enhances accuracy and predictive reliability, which is crucial for the effective deployment of DTs in biotechnology. The primary contribution is the development of a novel framework that synergistically combines CNN and FL, augmented by the capabilities of the IoBNT. This novel approach is specifically tailored to enhancing DTs in the biotechnology industry. The results showcase enhancements in the reliability and safety of microorganism DTs, while preserving their accuracy. Furthermore, the proposed framework excels in energy efficiency and security, offering a user-friendly and adaptable solution. This broadens its applicability across diverse sectors, including biotechnology and pharmaceutical industries, as well as clinical and hospital settings.